CAR-T细胞对改良MCF-7乳腺癌症细胞系的细胞毒性作用。

IF 1.5 Q4 BIOCHEMISTRY & MOLECULAR BIOLOGY
Aigul Kh Valiullina, Ekaterina A Zmievskaya, Irina A Ganeeva, Margarita N Zhuravleva, Ekaterina E Garanina, Albert A Rizvanov, Alexey V Petukhov, Emil R Bulatov
{"title":"CAR-T细胞对改良MCF-7乳腺癌症细胞系的细胞毒性作用。","authors":"Aigul Kh Valiullina,&nbsp;Ekaterina A Zmievskaya,&nbsp;Irina A Ganeeva,&nbsp;Margarita N Zhuravleva,&nbsp;Ekaterina E Garanina,&nbsp;Albert A Rizvanov,&nbsp;Alexey V Petukhov,&nbsp;Emil R Bulatov","doi":"10.22099/mbrc.2023.47125.1820","DOIUrl":null,"url":null,"abstract":"<p><p>The most often diagnosed and fatal malignancy in women is breast cancer. The International Agency for Research on Cancer (IARC) estimates that there are 2.26 million new cases of cancer in 2020. Adoptive cell therapy using T cells with chimeric antigen receptor shows potential for the treatment of solid tumors, such as breast cancer. In this work the effectiveness of CAR-T cells against monolayer and three-dimensional bioprinted tumor-like structures made of modified MCF-7 breast cancer cells was assessed. The cytokine profile of supernatants after co-cultivation of MCF-7 tumor cell models with CAR-T cells was also measured to reveal the inflammatory background associated with this interaction.</p>","PeriodicalId":19025,"journal":{"name":"Molecular Biology Research Communications","volume":"12 4","pages":"139-148"},"PeriodicalIF":1.5000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10599594/pdf/","citationCount":"0","resultStr":"{\"title\":\"Сytotoxic effect of CAR-T cells against modified MCF-7 breast cancer cell line.\",\"authors\":\"Aigul Kh Valiullina,&nbsp;Ekaterina A Zmievskaya,&nbsp;Irina A Ganeeva,&nbsp;Margarita N Zhuravleva,&nbsp;Ekaterina E Garanina,&nbsp;Albert A Rizvanov,&nbsp;Alexey V Petukhov,&nbsp;Emil R Bulatov\",\"doi\":\"10.22099/mbrc.2023.47125.1820\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The most often diagnosed and fatal malignancy in women is breast cancer. The International Agency for Research on Cancer (IARC) estimates that there are 2.26 million new cases of cancer in 2020. Adoptive cell therapy using T cells with chimeric antigen receptor shows potential for the treatment of solid tumors, such as breast cancer. In this work the effectiveness of CAR-T cells against monolayer and three-dimensional bioprinted tumor-like structures made of modified MCF-7 breast cancer cells was assessed. The cytokine profile of supernatants after co-cultivation of MCF-7 tumor cell models with CAR-T cells was also measured to reveal the inflammatory background associated with this interaction.</p>\",\"PeriodicalId\":19025,\"journal\":{\"name\":\"Molecular Biology Research Communications\",\"volume\":\"12 4\",\"pages\":\"139-148\"},\"PeriodicalIF\":1.5000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10599594/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Molecular Biology Research Communications\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.22099/mbrc.2023.47125.1820\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"BIOCHEMISTRY & MOLECULAR BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular Biology Research Communications","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.22099/mbrc.2023.47125.1820","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

女性最常被诊断和致命的恶性肿瘤是乳腺癌症。国际癌症研究机构(IARC)估计,2020年癌症新增病例226万例。使用具有嵌合抗原受体的T细胞的过继细胞疗法显示出治疗实体瘤(如乳腺癌症)的潜力。在这项工作中,评估了CAR-T细胞对抗由修饰的MCF-7乳腺癌症细胞制成的单层和三维生物打印肿瘤样结构的有效性。还测量了MCF-7肿瘤细胞模型与CAR-T细胞共培养后上清液的细胞因子谱,以揭示与这种相互作用相关的炎症背景。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Сytotoxic effect of CAR-T cells against modified MCF-7 breast cancer cell line.

Сytotoxic effect of CAR-T cells against modified MCF-7 breast cancer cell line.

Сytotoxic effect of CAR-T cells against modified MCF-7 breast cancer cell line.

Сytotoxic effect of CAR-T cells against modified MCF-7 breast cancer cell line.

The most often diagnosed and fatal malignancy in women is breast cancer. The International Agency for Research on Cancer (IARC) estimates that there are 2.26 million new cases of cancer in 2020. Adoptive cell therapy using T cells with chimeric antigen receptor shows potential for the treatment of solid tumors, such as breast cancer. In this work the effectiveness of CAR-T cells against monolayer and three-dimensional bioprinted tumor-like structures made of modified MCF-7 breast cancer cells was assessed. The cytokine profile of supernatants after co-cultivation of MCF-7 tumor cell models with CAR-T cells was also measured to reveal the inflammatory background associated with this interaction.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Molecular Biology Research Communications
Molecular Biology Research Communications BIOCHEMISTRY & MOLECULAR BIOLOGY-
CiteScore
3.00
自引率
0.00%
发文量
12
期刊介绍: “Molecular Biology Research Communications” (MBRC) is an international journal of Molecular Biology. It is published quarterly by Shiraz University (Iran). The MBRC is a fully peer-reviewed journal. The journal welcomes submission of Original articles, Short communications, Invited review articles, and Letters to the Editor which meets the general criteria of significance and scientific excellence in all fields of “Molecular Biology”.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信